FA
BIO icon

FDx Advisors’s Bio-Rad Laboratories Class A BIO Stock Holding History

FDx Advisors’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-753
Closed -$243K – 380
2023
Q4 		$243K Buy
753
+155
+26% +$48.6K 0.02% 596
2023
Q3 		$214K Buy
+598
New +$231K 0.02% 586
2020
Q3 		– Sell
-738
Closed -$333K – 608
2020
Q2 		$333K Buy
+738
New +$326K 0.02% 424
2017
Q4 		– Sell
-1,832
Closed -$407K – 1243
2017
Q3 		$407K Sell
1,832
-794
-30% -$179K 0.01% 898
2017
Q2 		$594K Sell
2,626
-874
-25% -$190K 0.02% 714
2017
Q1 		$698K Sell
3,500
-226
-6% -$43.5K 0.02% 656
2016
Q4 		$679K Sell
3,726
-201
-5% -$34.3K 0.02% 653
2016
Q3 		$643K Sell
3,927
-483
-11% -$73.3K 0.03% 537
2016
Q2 		$631K Sell
4,410
-335
-7% -$47.8K 0.03% 510
2016
Q1 		$649K Sell
4,745
-18
-0.4% -$2.36K 0.03% 504
2015
Q4 		$660K Sell
4,763
-500
-10% -$69.3K 0.03% 469
2015
Q3 		$707K Sell
5,263
-83
-2% -$11.9K 0.06% 348
2015
Q2 		$805K Sell
5,346
-1,954
-27% -$280K 0.04% 400
2015
Q1 		$993K Sell
7,300
-421
-5% -$52.2K 0.02% 605
2014
Q4 		$931K Sell
7,721
-22
-0.3% -$2.53K 0.06% 326
2014
Q3 		$878K Sell
7,743
-279
-3% -$33.1K 0.06% 364
2014
Q2 		$960K Buy
8,022
+2
+0% +$244 0.06% 341
2014
Q1 		$1.03M Sell
8,020
-33
-0.4% -$4.23K 0.09% 242
2013
Q4 		$995K Sell
8,053
-219
-3% -$26.7K 0.1% 198
2013
Q3 		$972K Buy
8,272
+20
+0.2% +$2.36K 0.11% 167
2013
Q2 		$926K Buy
+8,252
New +$968K 0.12% 162

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

FDx Advisors's BIO Position: Q1 2024 in Review

FDx Advisors sold out of Bio-Rad Laboratories Class A (BIO) in Q1 2024, closing a stake of 753 shares — an estimated $243K sold.

FDx Advisors first reported a position in BIO in Q2 2013 and held it in 21 quarters. The position peaked at $1.03M in Q1 2014. 467 funds tracked by Wall St. Rank hold BIO as of Q1 2024.

  • FDx Advisors reported no remaining Bio-Rad Laboratories Class A position as of Q1 2024 after selling out during the quarter.
  • FDx Advisors sold 753 Bio-Rad Laboratories Class A shares in Q1 2024, an estimated $243K.
  • FDx Advisors first reported a position in Bio-Rad Laboratories Class A in Q2 2013 and held it in 21 quarters.
  • FDx Advisors's Bio-Rad Laboratories Class A position peaked at $1.03M in Q1 2014.
  • 467 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2024.

Based on FDx Advisors's 13F filing for Q1 2024, filed 3 May 2024.